|
In the present era, clinical research has moved forward in its speed to battle against infections to develop better treatment options r on. Life science scientists worldwide endeavor steadily to investigate the more current clinical research methods, which are more advantageous and prudent with excellent quality. While the competition between the pharmaceutical organizations increases, there is a squeezing and rising demand for quality research to discover a significant breakthrough. Obviously, clinical trials on human subjects are both riskier and cost unwieldy for the sponsoring organizations. Moreover, in any clinical trial, enrolment of the appropriate study groups and its maintenance from the beginning of the clinical trial to the closeout and forthcoming follow-up is highly difficult. On the other hand, monitoring the research process and obtaining the final data evaluation depends on the retention of the principal investigator and research participants. Therefore, a sound strategy and sustainable human model are needed to cope with the current situation.
|
